Correlation Between Bristol Myers and NexGel Warrant

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and NexGel Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and NexGel Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and NexGel Warrant, you can compare the effects of market volatilities on Bristol Myers and NexGel Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of NexGel Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and NexGel Warrant.

Diversification Opportunities for Bristol Myers and NexGel Warrant

0.37

Correlation Coefficient

Bristol Myers  NexGel Warrant

Weak diversification

The 3 months correlation between Bristol and NexGel is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and NexGel Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NexGel Warrant and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with NexGel Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NexGel Warrant has no effect on the direction of Bristol Myers i.e., Bristol Myers and NexGel Warrant go up and down completely randomly.

Pair Corralation between Bristol Myers and NexGel Warrant

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the NexGel Warrant. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 9.6 times less risky than NexGel Warrant. The stock trades about -0.04 of its potential returns per unit of risk. The NexGel Warrant is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  46.00  in NexGel Warrant on October 11, 2024 and sell it today you would earn a total of  19.00  from holding NexGel Warrant or generate 41.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  NexGel Warrant

Bristol Myers Squibb

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in February 2025.

NexGel Warrant

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NexGel Warrant are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal essential indicators, NexGel Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and NexGel Warrant

The main advantage of trading using opposite Bristol Myers and NexGel Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, NexGel Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NexGel Warrant will offset losses from the drop in NexGel Warrant's long position.

The idea behind Bristol Myers Squibb and NexGel Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.